2014
DOI: 10.3390/ph7060662
|View full text |Cite
|
Sign up to set email alerts
|

A Bombesin-Shepherdin Radioconjugate Designed for Combined Extra- and Intracellular Targeting

Abstract: Radiolabeled peptides which target tumor-specific membrane structures of cancer cells represent a promising class of targeted radiopharmaceuticals for the diagnosis and therapy of cancer. A potential drawback of a number of reported radiopeptides is the rapid washout of a substantial fraction of the initially delivered radioactivity from cancer cells and tumors. This renders the initial targeting effort in part futile and results in a lower imaging quality and efficacy of the radiotracer than achievable. We ar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
11
0
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(12 citation statements)
references
References 45 publications
0
11
0
1
Order By: Relevance
“…Because this study aims at the investigation of differences in the pharmacokinetics of the radiopeptides (e.g., rate and route of excretion) rather than in tumor uptake, we continued with the evaluation of both compounds in vivo. The receptor affinity (K d ) and maximum receptor occupancy (B max ) were determined by receptor saturation assays using increasing amounts of the radiolabeled peptides ( Figure 3 [18,23,27], yet in this case somewhat surprising as we did not expect the sorbitol moiety to have an influence on these parameters; this in particular because the results of cell binding and internalization experiments were similar for both radiolabeled peptides ( Figure 2). Differences in specific molar activities (MBq/mol) could account for this observation and cannot be entirely excluded even though both 99m Tc-radiopeptides were prepared under identical conditions.…”
Section: Logdmentioning
confidence: 94%
See 1 more Smart Citation
“…Because this study aims at the investigation of differences in the pharmacokinetics of the radiopeptides (e.g., rate and route of excretion) rather than in tumor uptake, we continued with the evaluation of both compounds in vivo. The receptor affinity (K d ) and maximum receptor occupancy (B max ) were determined by receptor saturation assays using increasing amounts of the radiolabeled peptides ( Figure 3 [18,23,27], yet in this case somewhat surprising as we did not expect the sorbitol moiety to have an influence on these parameters; this in particular because the results of cell binding and internalization experiments were similar for both radiolabeled peptides ( Figure 2). Differences in specific molar activities (MBq/mol) could account for this observation and cannot be entirely excluded even though both 99m Tc-radiopeptides were prepared under identical conditions.…”
Section: Logdmentioning
confidence: 94%
“…The receptor affinity (Kd) and maximum receptor occupancy (Bmax) were determined by receptor saturation assays using increasing amounts of the radiolabeled peptides ( Figure 3 (13)] (Kd = 3.7 ± 1.0 nM, Bmax = 0.37 ± 0.02 nM; Table 2) [23]. Some variability in experimentally determined Kd and Bmax of structurally related radiolabeled peptides is not uncommon [18,23,27], yet in this case somewhat surprising as we did not expect the sorbitol moiety to have an influence on these parameters; this in particular because the results of cell binding and internalization experiments were similar for both radiolabeled peptides ( Figure 2). Differences in specific molar activities (MBq/mol) could account for this observation and cannot be entirely excluded even though both 99m Tc-radiopeptides were prepared under identical conditions.…”
Section: Logdmentioning
confidence: 99%
“…Radioconjugates consisting of two different molecular moieties in the same agent have been designed in order to combine different imaging modalities such as single photon emission computed tomography (SPECT) and near‐infrared (NIR) optical imaging or to associate the therapeutic effect of cytotoxic drugs with imaging ability . Diverse multifunctional radioconjugates have also been prepared to enhance cellular retention and internalization and to potentiate their uptake in specific subcellular localizations such as the nucleus and the mitochondria . The enhancement of nuclear uptake has been particularly important in the design of radioconjugates intended for auger electron therapy (AET).…”
Section: Methodsmentioning
confidence: 99%
“…Unfortunately, while the specificity of the radioconjugates towards the gastrin-releasing peptide receptor (GRPr) could be confirmed, the cellular externalisation of the radioactivity was not improved (Scheme 2) [6]. …”
mentioning
confidence: 99%
“…An example of how a radiotracer could be entrapped after binding to the chosen receptor is given by Fischer CA et al with the contribution A Bombesin-Shepherdin Radioconjugate Designed for Combined Extra- and Intracellular Targeting . Unfortunately, while the specificity of the radioconjugates towards the gastrin-releasing peptide receptor (GRPr) could be confirmed, the cellular externalisation of the radioactivity was not improved ( Scheme 2 ) [ 6 ].…”
mentioning
confidence: 99%